Why polymer compounding traceability is the product
A compounder ships pellets — but what the brand owner, the medical-device OEM and the pharma packager pay for is the Declaration of Compliance, the MoA, the migration / extractables file and the lot lineage behind them.
Plastics compounders and converters supply downstream regulators directly: 21 CFR 174–179 (food-contact substances), EU 10/2011 with the framework Reg 1935/2004 and the GMP Reg 2023/2006, UK SI 2012/2619 — each requires the compounder to issue a written Declaration of Compliance (DoC) per resin lot or grade, listing every monomer, additive, colorant and processing aid, with the relevant authorisations and any specific migration limits (SML) and dual-use additive constraints.
Medical-grade resins add USP <87> / <88> biological reactivity, ISO 10993-1 evaluation strategy, animal-derived material declarations where applicable, and full sub-tier additive disclosure to the device OEM's design history file.
V5 Ultimate treats every resin lot, every additive dispense, every extruder cycle, every QC test (MFI, color ΔE, moisture, migration where in-house) and every DoC / CoA / MoA issued as part of the same immutable ledger. A customer DoC challenge is a query. The food-contact or medical-grade claim is bound to the recipe and the lot — it cannot drift.
- EU 10/2011Plastic materials and articles intended to come into contact with food
- EU 2023/2006GMP for materials and articles intended to come into contact with food
- 21 CFR 174–179Indirect food additives — adhesives, polymers, paper, adjuvants
- USP <87> / <88>Biological reactivity in vitro / in vivo
